Semaphorin 3A promotes the long-term persistence of human SVF-derived microvascular networks in engineered grafts
In conclusion, Sema3A is a potent stimulator of <i>in vivo</i> long-term persistence of microvascular networks derived from human SVF. Therefore, decoration of matrices with Sema3a can be envisioned to promote the functional support of tissue engineered grafts.
Authors
- Andrea Banfi (ORCID: https://orcid.org/0000-0001-5737-8811)
- Jeffrey A. Hubbell (ORCID: https://orcid.org/0000-0003-0276-5456)
- Dirk J. Schaefer (ORCID: https://orcid.org/0000-0002-9619-8650)
- Maximilian G. Burger (ORCID: https://orcid.org/0000-0001-5575-5740)
- Nunzia Di Maggio (ORCID: https://orcid.org/0000-0001-8007-6782)
- Elisabeth A. Kappos (ORCID: https://orcid.org/0000-0003-4057-1951)
- Priscilla S. Briquez (ORCID: https://orcid.org/0000-0002-4680-9636)
- Juan M. Schwager (ORCID: https://orcid.org/0000-0002-5778-9992)
- Abeelan Rasadurai (ORCID: https://orcid.org/0000-0002-6559-2823)
- Andrea Grosso (ORCID: https://orcid.org/0000-0003-3145-3355)
- Nadja Minder
Institutions
- University of Freiburg (DE)
- University of Basel (CH)
- University Medical Center Freiburg (DE)
- University Hospital of Basel (CH)
- University of Chicago (US)
Publication Details
- Journal
- Frontiers in Bioengineering and Biotechnology
- Published
- 2024-08-21
- DOI
- https://doi.org/10.3389/fbioe.2024.1396450
- Citations
- 2
- Primary Topic
- Angiogenesis and VEGF in Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- National Science Foundation
- Baxter International
- European Commission
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Horizon 2020 Framework Programme